Entrada Therapeutics, Inc. (TRDA)
13.08
-0.40
(-2.97%)
USD |
NASDAQ |
Apr 02, 15:04
Entrada Therapeutics Research and Development Expense (TTM) : 136.44M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Tyra Biosciences, Inc. | 102.38M |
| EyePoint Plc | 221.04M |
| Vertex Pharmaceuticals, Inc. | 3.929B |
| Kodiak Sciences, Inc. | 182.37M |
| Arcutis Biotherapeutics, Inc. | 77.05M |